06855.HK
Ascentage Pharma Group International Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 29.56
−1.34%Margins
Gross margin
81.6%
EBITDA margin
-205.3%
EBIT margin
-218.7%
Net margin
-228.6%
FCF margin
-221.2%
-260.0%
Return on equity
-44.6%
Return on assets
-52.2%
Return on invested capital
0.18x
Asset turnover
-HKD 1.6B
Cash from operations
HKD 6.22
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026